• The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'.
Auteur:Atalay, G; Dirix, Luc Y; Biganzoli, Laura; Beex, Louk; Nooij, Marianne; Cameron, David A; Lohrisch, C; Cufer, T; Lobelle, Jean Pierre; Mattiaci, M R; Piccart-Gebhart, Martine; Paridaens, R.
Informations sur la publication:Annals of oncology, 15, 2, page (211-217)
Statut de publication:Publié, 2004-02
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged, 80 and over
Androstadienes -- pharmacology
Androstadienes -- therapeutic use
Antineoplastic Agents, Hormonal -- pharmacology
Antineoplastic Agents, Hormonal -- therapeutic use
Aromatase Inhibitors
Arteriosclerosis -- etiology
Arteriosclerosis -- prevention & control
Breast Neoplasms -- drug therapy
Breast Neoplasms -- pathology
Cholesterol -- blood
Enzyme Inhibitors -- pharmacology
Enzyme Inhibitors -- therapeutic use
Lipids -- blood
Middle Aged
Neoplasm Metastasis
Risk Factors
Tamoxifen -- pharmacology
Tamoxifen -- therapeutic use
Note générale:Clinical Trial
Clinical Trial, Phase II
Journal Article
Multicenter Study
Randomized Controlled Trial